CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway

PDGFRα in Liver Pathophysiology: Emerging Roles in Development, Regeneration, Fibrosis, and Cancer

(2015) Alexander Kikuchi et al.   GENE EXPRESSION

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Pyk2 and Src Mediate Signaling to CCL18-Induced Breast Cancer Metastasis

(2013) Hai-Yan Li et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Identification of human CCR8 as a CCL18 receptor

(2013) Sabina A. Islam et al.   JOURNAL OF EXPERIMENTAL MEDICINE

PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations

(2013) A I Velghe et al.   ONCOGENE

Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer

(2012) Donghui Li et al.   CARCINOGENESIS

Cytokine Network: New Targeted Therapy for Pancreatic Cancer

(2012) Yoichi Matsuo et al.   CURRENT PHARMACEUTICAL DESIGN

Cancer-Related Inflammation

(2012) Juliana Candido et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis

(2012) T. Miyagaki et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Inhibition of mTORC2 but not mTORC1 Up-Regulates E-Cadherin Expression and Inhibits Cell Motility by Blocking HIF-2α Expression in Human Renal Cell Carcinoma

(2012) Shintaro Maru et al.   JOURNAL OF UROLOGY

CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer

(2012) Virginia Urquidi et al.   PLoS One

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

(2011) Jingqi Chen et al.   CANCER CELL

Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated

(2011) Julia S. Pettersen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

mTOR links oncogenic signaling to tumor cell metabolism

(2011) Jessica L. Yecies et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Fractalkine Receptor CX3CR1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells

(2011) M. Kim et al.   MOLECULAR CANCER RESEARCH

Ovarian Cancer Development and Metastasis

(2010) Ernst Lengyel   AMERICAN JOURNAL OF PATHOLOGY

Tuberous Sclerosis Complex 2 (TSC2) Regulates Cell Migration and Polarity through Activation of CDC42 and RAC1

(2010) Yan Larson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells

(2010) J. Catusse et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma

(2010) Maria V. Barbolina et al.   MOLECULAR CANCER RESEARCH

Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC–MS/MS

(2010) Richard D Unwin et al.   Nature Protocols

Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis

(2009) Antje Prasse et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

(2009) N. Cabioglu et al.   ANNALS OF ONCOLOGY

mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice

(2009) David A. Guertin et al.   CANCER CELL

CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages

(2009) David G. DeNardo et al.   CANCER CELL

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

mTOR and cancer: many loops in one pathway

(2009) Alejo Efeyan et al.   CURRENT OPINION IN CELL BIOLOGY

Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer

(2009) Samir F. Zohny et al.   MEDICAL ONCOLOGY

CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders

(2009) C.-Y. Chang et al.   NEUROSCIENCE

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein

(2009) M R Abedini et al.   ONCOGENE

Alternative Activation of Macrophages: An Immunologic Functional Perspective

(2008) Fernando O. Martinez et al.   Annual Review of Immunology